N-methyl-imidazole derivatives as anti-mycotic agents
    2.
    发明授权
    N-methyl-imidazole derivatives as anti-mycotic agents 失效
    N-甲基 - 咪唑衍生物作为抗真菌剂

    公开(公告)号:US3934014A

    公开(公告)日:1976-01-20

    申请号:US474873

    申请日:1974-05-31

    摘要: N-methyl-imidazole derivatives of the formula: ##EQU1## or a pharmaceutically acceptable non-toxic salt thereof, wherein X is an unsubstituted or substituted 6-membered heteroaromatic moiety having two nitro heteroatoms,Y is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety or an unsubstituted or substituted aryl moiety, andZ is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety, an unsubstituted or substituted aryl moiety, an unsubstituted or substituted pyridyl moiety or an alkoxycarbonyl moiety,Are useful as antimycotic agents.

    摘要翻译: 其中X是具有两个硝基杂原子的未取代或取代的6元杂芳族部分,Y是一个 未取代或取代的脂族部分,未取代或取代的脂环族部分,未取代或取代的芳烷基部分或未取代或取代的芳基部分,Z为未取代或取代的脂族部分,未取代或取代的脂环族部分,未取代或取代的芳烷基部分 ,未取代或取代的芳基部分,未取代或取代的吡啶基部分或烷氧基羰基部分,可用作抗生药剂。

    N-methyl-imidazole derivatives for treating mycotic infections
    3.
    发明授权
    N-methyl-imidazole derivatives for treating mycotic infections 失效
    用于治疗真菌感染的N-甲基 - 咪唑衍生物

    公开(公告)号:US4062959A

    公开(公告)日:1977-12-13

    申请号:US554009

    申请日:1975-02-28

    摘要: N-methyl-imidazole derivatives of the formula: ##STR1## or a pharmaceutically acceptable non-toxic salt thereof, wherein X is an unsubstituted or substituted 6-membered heteroaromatic moiety having two nitro heteroatoms,Y is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety or an unsubstituted or substituted aryl moiety, andZ is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety, an unsubstituted or substituted aryl moiety, an unsubstituted or substituted pyridyl moiety or an alkoxycarbonyl moiety,Are useful as antimycotic agents.

    摘要翻译: 式(I)的N-甲基 - 咪唑衍生物或其药学上可接受的无毒盐,其中X是具有两个硝基杂原子的未取代或取代的6元杂芳族部分,Y是未取代或取代的脂族 未取代或取代的脂环族部分,未取代或取代的芳烷基部分或未取代或取代的芳基部分,Z为未取代或取代的脂族部分,未取代或取代的脂环族部分,未取代或取代的芳烷基部分,未取代或取代的芳烷基部分, 取代的芳基部分,未取代或取代的吡啶基部分或烷氧基羰基部分,可用作抗生药剂。

    N-Methyl-imidazole derivatives for treating mycotic infections
    4.
    发明授权
    N-Methyl-imidazole derivatives for treating mycotic infections 失效
    用于治疗真菌感染的N-甲基 - 咪唑衍生物

    公开(公告)号:US3980780A

    公开(公告)日:1976-09-14

    申请号:US554203

    申请日:1975-02-28

    摘要: N-methyl-imidazole derivatives of the formula: ##EQU1## or a pharmaceutically acceptable non-toxic salt thereof, wherein X is an unsubstituted or substituted 6-membered heteroaromatic moiety having two nitro heteroatoms,Y is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety or an unsubstituted or substituted aryl moiety, andZ is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety, an unsubstituted or substituted aryl moiety, an unsubstituted or substituted pyridyl moiety or an alkoxycarbonyl moiety,Are useful as antimycotic agents.

    摘要翻译: 其中X是具有两个硝基杂原子的未取代或取代的6元杂芳族部分,Y是未取代的或未取代的或未取代的 取代的脂族部分,未取代或取代的脂环族部分,未取代或取代的芳烷基部分或未取代或取代的芳基部分,Z是未取代或取代的脂族部分,未取代或取代的脂环族部分,未取代或取代的芳烷基部分, 未取代或取代的芳基部分,未取代或取代的吡啶基部分或烷氧基羰基部分,作为抗菌剂有用。

    Diaryl-pyridyl-imidazole methanes for treating mycotic infections
    5.
    发明授权
    Diaryl-pyridyl-imidazole methanes for treating mycotic infections 失效
    用于治疗真菌感染的二芳基 - 吡啶基 - 咪唑甲烷

    公开(公告)号:US3969522A

    公开(公告)日:1976-07-13

    申请号:US557354

    申请日:1975-03-11

    IPC分类号: A61K31/44

    CPC分类号: A61K31/44

    摘要: Diaryl-pyridyl-imidazolyl methanes of the formula ##SPC1##And pharmaceutically acceptable non-toxic salts thereof, wherein R.sup.1 and R.sup.2 are the same or different alkyl of 1 to 4 carbon atoms, are produced either byA. reacting a (dialkylphenyl-phenyl-pyridyl)-methanol of the formula ##SPC2##Wherein R.sup.1 and R.sup.2 are as above defined, with thionyl-bis-imidazole in the presence of an inert organic diluent at a temperature of from -20.degree. C to about 150.degree. C; orB. reacting a (dialkylphenyl-phenyl-pyridyl)-methyl halide of the formula ##SPC3##Wherein R.sup.1 and R.sup.2 are as above defined and Hal is chlorine or bromine, with imidazole in the presence of an acid binding agent at a temperature of from 20.degree. C to about 180.degree.C. The diaryl-pyridyl-imidazole methanes of the present invention are useful for their antimycotic activity.

    摘要翻译: 式II的二芳基 - 吡啶基 - 咪唑基甲烷及其药学上可接受的非毒性盐,其中R 1和R 2是相同或不同的1至4个碳原子的烷基,由A.产生A(对二苯基苯基 - 吡啶基) 在惰性有机稀释剂存在下,在-20℃至约150℃的温度下,在亚甲基 - 双 - 咪唑存在的情况下,R1和R2如上所定义。 或B.反应式(R 1和R 2如上所定义),并且Hal是氯或溴,在酸性粘合剂存在下,在20℃的温度下,将式(1)中的(对二苯基苯基) - 吡啶基 - 本发明的二芳基 - 吡啶基 - 咪唑甲烷可用于其抗真菌活性。

    Imidazolylacetic acid amides, their production, antimycotic compositions
comprising said compounds and their use as antimycotic agents
    7.
    发明授权
    Imidazolylacetic acid amides, their production, antimycotic compositions comprising said compounds and their use as antimycotic agents 失效
    咪唑啉酸,它们的生产,含有化合物的抗微生物组合物及其作为抗菌剂的用途

    公开(公告)号:US4032636A

    公开(公告)日:1977-06-28

    申请号:US651419

    申请日:1976-01-22

    CPC分类号: C07D417/06 A61K31/415

    摘要: Imidazolylacetic acid amides of the formula: ##STR1## or pharmaceutically acceptable nontoxic salts thereof wherein either R.sup.1 is phenyl or cycloalkyl, unsubstituted or substituted by one or more substituents; andR.sup.2 is hydrogen; orR.sup.1 and R.sup.2, together with the nitrogen atom to which they are attached, form a saturated 5 to 7-membered heterocyclic ring which ring may contain an --SO.sub.2 -- or --NY-- moiety wherein Y is alkoxycarbonyl, dialkylaminocarbonyl, or phenyl or diphenylmethyl, unsubstituted or substituted by one or more substituents and wherein said 5 to 7-membered heterocyclic ring itself is otherwise unsubstituted or substituted by one or more substituents; andX.sup.1, x.sup.2, x.sup.3 and X.sup.4 are the same or different and are each hydrogen or halogen,Are produced byA. reacting a halodiphenylacetic acid amide of the formula: ##STR2## wherein R.sup.1, R.sup.2, X.sup.1, X.sup.2, X.sup.3 and X.sup.4 are as above defined, and Hal is halogen,With imidazole; orB. reacting a halodiphenylacetic acid halide of the formula- ##STR3## WHEREIN X.sup.1, X.sup.2, X.sup.3 and X.sup.4 are as above defined and Hal is halogenWith imidazole to produce an imidazolide of the formula: ##STR4## wherein X.sup.1, X.sup.2, X.sup.3 and X.sup.4 are as above defined which in turn is transaminated by reaction with an amine of the formula:NHR.sup.1 R.sup.2whereinR.sup.1 and R.sup.2 are as above defined.

    Antimycotic compositions containing an imidazolylacetic acid amide or
salt thereof as the active agent and the use thereof in the treatment
of mycoses
    9.
    发明授权
    Antimycotic compositions containing an imidazolylacetic acid amide or salt thereof as the active agent and the use thereof in the treatment of mycoses 失效
    含有咪唑基乙酰胺或其盐作为活性剂的抗真菌组合物及其在治疗真菌病中的应用

    公开(公告)号:US4024270A

    公开(公告)日:1977-05-17

    申请号:US594195

    申请日:1975-07-09

    IPC分类号: A61K31/415 C07D417/06

    CPC分类号: C07D417/06 A61K31/415

    摘要: Pharmaceutical compositions useful for treating mycotic infections in humans and animals are produced which comprise an antimycotically effective amount of an imidazolylacetic acid amide of the formula: ##STR1## or pharmaceutically acceptable nontoxic salts thereof WHEREINEitherR.sup.1 is phenyl or cycloalkyl, unsubstituted or substituted by one or more substituents; andR.sup.2 is hydrogen;OrR.sup.1 and R.sup.2, together with the nitrogen atom to which they are attached, form a saturated 5 to 7-membered heterocyclic ring which ring may contain an --SO.sub.2 -- or --NY-- moiety wherein Y is alkoxycarbonyl, dialkylaminocarbonyl, or phenyl or diphenylmethyl, unsubstituted or substituted by one or more substituents and wherein said 5 to 7-membered heterocyclic ring itself is otherwise unsubstituted or substituted by one or more substituents; andX.sup.1, x.sup.2, x.sup.3 and X.sup.4 are the same or different and are each hydrogen or halogen,Are produced byA. reacting a halodiphenylacetic acid amide of the formula: ##STR2## wherein R.sup.1, R.sup.2, X.sup.1, X.sup.2, X.sup.3 and X.sup.4 are as above defined, and Hal is hydrogen,With imidazole; orB. reacting a halodiphenylacetic acid halide of the formula: ##STR3## WHEREIN X.sup.1, X.sup.2, X.sup.3 and X.sup.4 are as above defined and Hal is hydrogenWith imidazole to produce an imidazolide of the formula: ##STR4## wherein X.sup.1, X.sup.2, X.sup.3 and X.sup.4 are as above definedwhich in turn is transaminated by reaction with an amine of the formula:NHR.sup.1 R.sup.2whereinR.sup.1 and R.sup.2 are as above defined.

    摘要翻译: 产生用于治疗人和动物中的真菌感染的药物组合物,其包含抗真菌有效量的下式的咪唑基乙酰胺或其药学上可接受的无毒盐,其中R1是未取代或被一个取代的苯基或环烷基 或更多取代基; R2是氢; OR R1和R2与它们连接的氮原子一起形成饱和的5至7元杂环,该环可以含有-SO 2 - 或-NY-部分,其中Y是烷氧基羰基,二烷基氨基羰基或苯基或二苯基甲基 未取代或被一个或多个取代基取代,并且其中所述5至7元杂环本身是未取代的或被一个或多个取代基取代; 并且X 1,X 2,X 3和X 4相同或不同,各自为氢或卤素,由A制备。反应式为二氢苯甲酸的酰胺:其中R 1,R 2,X 1,X 2,X 3和X 4为 如上所定义,Hal是氢,具有咪唑; 或B.反应式中的卤代苯甲酸:其中X 1,X 2,X 3和X 4如上所定义,Hal是具有咪唑并氢的氢,以制备式I的咪唑烷:其中X1,X2,X3 和X 4如上所定义,其又通过与下式的胺反应进行转氨:

    1,2,4-Triazole antimycotic compositions and use thereof
    10.
    发明授权
    1,2,4-Triazole antimycotic compositions and use thereof 失效
    1,2,4-三唑抗真菌组合物及其用途

    公开(公告)号:US4002763A

    公开(公告)日:1977-01-11

    申请号:US532191

    申请日:1974-12-12

    IPC分类号: C07D249/08 A61K31/41

    摘要: Antimycotic compositions are produced which comprise an antimycotically effective amount of a 1,2,4-triazole of the formula: ##STR1## or a pharmaceutically acceptable non-toxic salt thereof wherein X.sup.1 is hydrogen or alkyl;X.sup.2 is hydrogen or alkyl;R.sup.1 is alkyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl;R.sup.2 is hydrogen, alkyl or unsubstituted or substituted aryl;R.sup.3 is alkyl, cycloalkyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl; andY is a keto group of a functional derivative of a keto group, in combination with a pharmaceutically acceptable non-toxic, inert diluent or carrier.

    摘要翻译: 产生抗真菌组合物,其包含抗真菌有效量的下式的1,2,4-三唑或其药学上可接受的无毒盐,其中X 1是氢或烷基; X2是氢或烷基; R1是烷基,未取代或取代的芳基或未取代或取代的芳烷基; R2是氢,烷基或未取代或取代的芳基; R3是烷基,环烷基,未取代或取代的芳基或未取代或取代的芳烷基; 和Y是酮基的功能性衍生物的酮基,其与药学上可接受的无毒惰性稀释剂或载体的组合。